Top Markets
#1 0G 0G +38.08%
#2 Axelar Axelar +22.24%
#3 Fake World Assets Fake World Assets +21.37%
#4 Bless Bless +19.68%
#5 Full Moon Full Moon +18.88%
#6 VVS Finance VVS Finance +18.18%
#7 Zora Zora +17.80%
#8 StonkBroker StonkBroker +16.79%
#9 Merlin's Seal BTC Merlin's Seal BTC +16.45%
#10 ADO Protocol ADO Protocol +15.64%
Coin of the day
0G 0G
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Albireo Pharma, Inc. Albireo Pharma, Inc.

Albireo Pharma, Inc.

ALBO
Classifica tra le azioni #12828
Albireo Pharma, Inc. is a biopharmaceutical company with marketed products,... Albireo Pharma, Inc. is a biopharmaceutical company with marketed products, dedicated to researching, developing, and commercializing new treatments that modify bile acids. The company primarily targets rare liver diseases in children, as well as various other conditions affecting the liver or digestive system. Its portfolio includes Bylvay, a treatment approved for progressive familial intrahepatic cholestasis. Bylvay is also in advanced (Phase III) clinical trials for further pediatric indications such as biliary atresia and Alagille syndrome, which are both uncommon and serious childhood disorders. Additionally, Albireo offers Elobixibat, prescribed for the management of persistent constipation and other functional gastrointestinal issues. Albireo is further advancing its pipeline with A3907, currently undergoing early-stage (Phase I) clinical investigation for adult liver diseases, and A2342, a preclinical candidate designed to address adult viral and liver conditions. The company holds a licensing agreement with EA Pharma Co., Ltd. concerning the development and market rollout of Elobixibat. Albireo Pharma, Inc.'s headquarters are located in Boston, Massachusetts.
Prezzo delle azioni
$44.15
Ultima sincronizzazione: 2023-03-02
Capitalizzazione di mercato
$545.52M
Variazione (1 giorno)
-0.23%
Variazione (1 anno)
0.00%
Paese
US
Scambia Albireo Pharma, Inc. (ALBO)

Categoria

Healthcare
Storico del prezzo dell'azione per Albireo Pharma, Inc. (ALBO)
Prezzo di chiusura più alto: $44.20 il 2023-03-01

Prezzo di chiusura più basso: $22.42 il 2016-11-01
Storico del prezzo dell'azione di Albireo Pharma, Inc. dal 2016 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 111.85%
2022 -9.07%
2021 -41.92%
2020 72.73%
2019 -4.50%
2018 -3.43%
2017 12.42%
2016 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.76 6.28%
CH